Skip to main content

Table 1 Effect of plasma samples, cytokines and parasite products in the white blood cell aggregation assay

From: Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation

Expt. No.

Sample

% RCAI (Median)

25%

75%

1

NHP

5.80

1.6

7.3

2

PP

100

100.0

100.0

3

POPP

20.90

5.6

28.4

4

NHP+cytokines

17.20

6.7

23.5

5

NHP+PvAg

18.60

4.5

20.8

6

NHP+PvAg+ cytokines

88.50

79.8

92.4

7

NHP+RBC Ag+ cytokines

10.00

2.4

12.9

8

POPP+cytokines

18.30

7.5

22.3

9

POPP+PvAg

16.40

9.4

18.1

10

POPP+PvAg+ cytokines

77.10

64.7

79.8

11

NHP+LPS

6.10

1.9

7.2

12

NHP+LPS+cytokines

16.10

6.9

18.6

13

PP + IRS-Pv

24.90

15.6

28.4

14

PP + IRS-Pf

54.40

48.6

65.4

15

PP + CHS

17.00

14.2

19.5

  1. % RCAI: % Relative Cell Aggregation Index
  2. 25%–75%: 25th and 75th percentiles
  3. Normal human plasmas (NHP) and post paroxysm plasmas (POPP) were reconstituted with freeze-thawed extracts of P. vivax schizonts (Pv Ag), normal red cell extracts (RBC Ag), recombinant human cytokines TNF-, GM-CSF, IL-6 and IL-10 (cytokines) or E. coli lipopolysaccharide (LPS). P. vivax paroxysm plasma (PP) was pre-incubated with rabbit serum raised against P. vivax schizonts (IRS-Pv), with rabbit serum raised against P. falciparum schizonts (IRS-Pf) or with convalescent human serum (CHS) collected 4 – 6 weeks after drug cure of a P. vivax infection, from semi-immune individuals resident in a malaria-endemic area prior to being tested in the cell aggregation assay. The table provides the median values together with the interquartile range (25%–75%).